Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review

INTRODUCTION: Although dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting, the optimal duration is unknown. Recent evidence indicates there may be benefits in extending the duration beyond 12 months but such decisions may incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Jesse, Kelly, Shannon E, Bai, Zemin, Liu, Wenfei, Skidmore, Becky, Boucher, Michel, So, Derek Y F, Wells, George A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387937/
https://www.ncbi.nlm.nih.gov/pubmed/28377396
http://dx.doi.org/10.1136/bmjopen-2016-015421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387937/
https://www.ncbi.nlm.nih.gov/pubmed/28377396
http://dx.doi.org/10.1136/bmjopen-2016-015421

Ejemplares similares